Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,050,901
+$1,523,716 QoQ
Shares Held
728,147
+70.5% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ARVN ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,050,901 | 728,147 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,527,185 | 427,093 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $967,360 | 81,565 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $743,932 | 87,316 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,818,033 | 1,333,972 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,851,948 | 3,825,064 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $78,654,720 | 4,103,011 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $94,917,024 | 3,853,716 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $106,183,692 | 3,988,869 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $180,328,294 | 4,368,418 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $157,730,182 | 3,832,123 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $52,805,498 | 2,688,671 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $66,865,973 | 2,694,036 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $68,674,775 | 2,513,718 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $81,013,726 | 2,368,130 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $96,977,877 | 2,179,768 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $137,532,021 | 3,267,570 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $209,081,583 | 3,106,710 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $239,077,176 | 2,910,606 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $210,146,915 | 2,557,154 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $190,942,213 | 2,479,769 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $157,744,675 | 2,386,455 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $190,705,983 | 2,245,449 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $19,827,559 | 839,795 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $28,811,698 | 859,025 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,754,799 | 142,799 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||